Our Mission

By the same token, every human being has the freedom to change at any instant. Therefore, we can predict his future only within the large framework of a statistical survey referring to a whole group; the individual personality, however, remains essentially unpredictable. The basis for any predictions would be represented by biological, psychological or sociological conditions. Yet one of the main features of human existence is the capacity to rise above such conditions, to grow beyond them. Man is capable of changing the world for the better if possible, and of changing himself for the better if necessary.

Viktor Frankl: Man’s search for meaning. Beacon Press, Boston, 1962 edition, page 131

Work together with us!

We consult for various institutions and companies. Please contact us.

We help you to develop – or regain – your full potential. Please contact us.

Education and teaching belong to our most important tasks and responsibilities. Questions or suggestions? Contact us.

Our Latest Blogposts

Sunrise with Cariprazine

IQWiG: Indication of an Added Benefit of Cariprazine

The Institute for Quality and Efficiency in Health Care (IQWiG) on July 16, 2018, published its opinion on cariprazine as part of its „benefit assessment“. It concludes that there is an "indication" that cariprazine has a "non-quantifiable added benefit" in the group of patients with schizophrenia with predominant negative symptoms.
Withdrawal and Emotional Blunting with Chronic Antidepressant Treatment

How Common are Withdrawal and Emotional Blunting in Chronic Antidepressant Treatment?

The problem of withdrawal syndromes and emotional blunting occurring with prolonged antidepressant treatment is constantly underestimated by clinicians.
Crisis in Psychopharmacology

A Lecture on the "Crisis in Psychopharmacology"

Lecture on "The Crisis of Psychopharmacology" at the scientific colloquium of the Department of Psychiatry and Psychotherapy of the University of Rostock.
Launch Cariprazine 2018 Germany

Finally: A New Psychotropic Drug in Germany - Cariprazine

Recordati launched the new antipsychotic cariprazine in Germany in Mid-April. The benefit assessment by the G-BA has therefore started.
Antidepressants in the New York Times

The Antidepressant Debate in the New York Times

An article on the front page of the New York Times on April 7, 2018, has fueled the debate over antidepressants again.
Summer School Psychopharmacology 2018 in Berlin

DGPPN Summer School "Psychopharmacology" 2018 in Berlin

On June 28 and 29, 2018, the Summer School "Psychopharmacology", organized by the German Society for Psychiatry and Psychotherapy, Psychosomatics and Neuroscience (DGPPN), will be held in Berlin.
Mental Health Crisis

The Mental Health Crisis in Graduate Education

In the March issue of Nature Biotechnology, Teresa Evans of the University of San Antonio, Texas, and co-authors point out that there is "Evidence for a mental health crisis in graduate education".
antipsychotics long-term treatment

Antipsychotics for long-term treatment - when to stop? Or better not?

/
A new publication in the prestigious Lancet Psychiatry seems to provide new evidence for the benefits of long-term antipsychotic maintenance treatment in schizophrenia (Hui et al., Lancet Psychiatry 2018). On closer inspection, however, the paper confuses more than it provides new insights.
Gerhard Gründer at "Frag-den-Professor"

"Langzeittherapie mit Psychopharmaka" bei Frag-den-Professor

My presentation on "long-term treatment with psychotropic drugs" ("Langzeittherapie mit Psychopharmaka") on the web platform "Frag-den-Professor".